Transmucosal formulations

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/162, 167/103

A61K 9/50 (2006.01) A61K 9/16 (2006.01) A61K 47/00 (2006.01) A61K 37/02 (1990.01) A61K 37/24 (1990.01)

Patent

CA 1333258

High molecular weight drugs such as peptides are not well absorbed across biological membranes such as the nasal mucosa. Absorption can be increased if the drug is given together with an absorption enhancing material. However, it has been found that such material can have an irritant effect on the membrane. The invention provides a drug delivery composition for transmucosal delivery comprising a plurality of microspheres and active drug associated with each microsphere, the drug being for systemic delivery and having a maximum molecular weight of 6000 and the composition being substantially free of an enhancer. The microspheres may be starch, gelatin, collagen or dextran. The composition has been found to increase the absorption of drugs, particularly peptides such as insulin, across mucosal membranes. The compositions are suitable for delivery across mucosal surfaces such as the nose, vagina or eye.

579773

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Transmucosal formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transmucosal formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transmucosal formulations will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1256214

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.